[Effect of acute moderate isovolumic hemodilution on the pharmacokinetics of vecuronium].
Abstract
[OBJECTIVE] To determine the effect of acute moderate isovolemic hemodilution on pharmacokinetics of vecuronium.
[METHODS] Twenty-six adult patients, ASA grade I, undergoing elective plastic surgery, were randomly divided equally into the control and hemodilution group. The blood samples were taken for 5 hours following intravenous bolus of 100 micrograms/kg of vecuronium in two groups. The plasma concentrations of vecuronium were determined with an improved fluorometry and the pharmacokinetic parameters were obtained by fitting the data with a 3P87 program.
[RESULTS] The disposition of vecuronium can be best described by a three compartment open model. As comparison with the control group, the values of Vc and Vdss in hemodilution group were greater than that in the control, while T1/2 beta was markedly prolonged in this group. There were no significant differences in T1/2 phi, T1/2 alpha, K12, K21, K13, K31, K10, MRT, AUC, and Cl between the two groups.
[CONCLUSION] Acute moderate isovolemic hemodilution could change the pharmacokinetics of vecurinium, particularly in distribution and elimination phases.
[METHODS] Twenty-six adult patients, ASA grade I, undergoing elective plastic surgery, were randomly divided equally into the control and hemodilution group. The blood samples were taken for 5 hours following intravenous bolus of 100 micrograms/kg of vecuronium in two groups. The plasma concentrations of vecuronium were determined with an improved fluorometry and the pharmacokinetic parameters were obtained by fitting the data with a 3P87 program.
[RESULTS] The disposition of vecuronium can be best described by a three compartment open model. As comparison with the control group, the values of Vc and Vdss in hemodilution group were greater than that in the control, while T1/2 beta was markedly prolonged in this group. There were no significant differences in T1/2 phi, T1/2 alpha, K12, K21, K13, K31, K10, MRT, AUC, and Cl between the two groups.
[CONCLUSION] Acute moderate isovolemic hemodilution could change the pharmacokinetics of vecurinium, particularly in distribution and elimination phases.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | intravenous
|
scispacy | 1 | ||
| 해부 | plasma
|
scispacy | 1 | ||
| 해부 | K21
|
scispacy | 1 | ||
| 약물 | vecuronium
|
C0242531
vecuronium
|
scispacy | 1 | |
| 약물 | vecurinium
|
scispacy | 1 | ||
| 약물 | [OBJECTIVE]
|
scispacy | 1 | ||
| 약물 | ASA grade
|
scispacy | 1 | ||
| 질환 | hemodilution
|
C0019009
therapeutic hemodilution
|
scispacy | 1 | |
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | Vdss
|
scispacy | 1 | ||
| 기타 | K12
|
scispacy | 1 | ||
| 기타 | K13
|
scispacy | 1 | ||
| 기타 | K31
|
scispacy | 1 | ||
| 기타 | K10
|
scispacy | 1 |
MeSH Terms
Adolescent; Adult; Hemodilution; Humans; Neurofibroma; Neuromuscular Nondepolarizing Agents; Skull Neoplasms; Surgery, Plastic; Vecuronium Bromide